Cancer is the second most common cause of death in the European Union. New approaches are urgently needed to address the growing number of cancer cases diagnosed each year.
In the European Union:
- 1 in 4 deaths were caused by cancer in 2011
- 1.28 million deaths resulted from cancer in 2011
- 2.45 million new cancer cases were diagnosed in 2009
- Melanoma cases have doubled over the last 30 years
- The cost of drugs, healthcare, and earnings lost due to sickness was 126 billion in 2009
- 1 in 5 deaths or 20.8% of all cancer deaths were related to lung cancer in 2011
For decades, medical researchers have investigated different ways to empower the human body to better fight diseases such as cancer. Now, an emerging area of cancer research, called immuno-oncology, could potentially transform this objective into a reality, bringing new hope for many patients with cancer.
Breakthroughs in immuno-oncology are offering cancer patients new hope regarding the management of their condition and to have a better quality of life, while providing health providers the opportunity to deliver potentially unprecedented outcomes for people living with cancer.